Navigation Links
Bioheart Announces Acceptance of Marvel-1 Data for Presentation at the Heart Failure Society of America (HFSA) Meeting
Date:7/23/2009

SUNRISE, Fla., July 23 /PRNewswire-FirstCall/ -- Bioheart, Inc. (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced today acceptance of MARVEL-1 data for presentation at the Heart Failure Society of America (HFSA) Meeting September 13-16th, 2009 in Boston, Massachusetts.

Chris O'Connor, MD, Head of Heart Failure at Duke University and Thomas Povsic, MD, Ph.D., Assistant Professor of Medicine at Duke University will present the final data for Part 1 of the MARVEL Phase II/III Clinical Trial as a part of the Late Breaking Clinical Trials Session on September 16, 2009.

Doug Owens, RN, MPH, CCRA, Director of Clinical and Regulatory Affairs, at Bioheart, Inc., states "We are very excited about the positive results we have seen in the Marvel-Part 1 study and look forward to presenting the final data. We are eager to launch part two of the MARVEL Study and anticipate rapid enrollment upon re-initiation of the trial."

Bioheart, Inc. is committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to improve a patient's quality of life and reduce health care costs and hospitalizations. Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its lead product candidate, MyoCell((R)), is an innovative clinical muscle-derived stem cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. The Company's pipeline includes multiple product candidates for the treatment of heart damage, incl
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bioheart, Inc. Announces Receipt of $2.8 Million in Proceeds From Pipe Financing
2. Bioheart to Introduce Improved Heart Failure Monitoring Systems at Heart Failure Nurses Annual Meeting
3. Snoring Isn't Sexy, LLC Announces Commendation Program to Honor Sleep Physicians Who Work with Dentists to Manage Sleep Breathing Disorders
4. Cell Therapeutics, Inc. Announces Public Offering of Common Stock and Warrants
5. Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock
6. Human Genome Sciences Announces Second-Quarter 2009 Financial Results and Key Developments
7. Service Corporation International Announces Schedule For Its Second Quarter 2009 Earnings Release and Conference Call
8. Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study
9. TrinityCare Senior Living Announces Extension of Financing for Trinity Shores Facility in Port Lavaca, Texas
10. Cryo-Cell Announces Celle(SM) Research and Development Collaboration for Chronic Wound Healing Management
11. Nighttime Care Centers Announces New Urgent Care Medical Clinic in Montgomery County, Maryland

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...NGTON, Nov. 21 A region...nchocerciasis (river blindness) in the Americas ha...ase in recent years, as evidenced by a 31% decreas... administration in six endemic countries. Results... the American Society of Tropical Medicine and Hyg...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive g...d iPod Touch. , Mountain ...s most popular and addictive game, SplitWords, is ...Words is designed to help banish that ,tip of the ...one brain game challenges the brain by encouragin...
(Date:11/20/2009)...TON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST ...al Meeting of Shareholders will be held on Monday,...to consider approval of two special resolutions. T...orize the sale of all or substantially all of the ...ided for in the asset purchase agreement dated Nov...
(Date:11/20/2009)...SON, N.J., Nov. 20 Rates... have peaked in late October, but the pandemic flu...ss in all age groups, including the elderly, accor...ated (NYSE: DGX ), the world,s leading provider ...,, In its most recent Quest Diagnostics Health ...
(Date:11/20/2009)...S, Nov. 20 The followin...tor of the Nevada Health Care Association: ,, "... and thanks Senate Majority Leader Harry Reid for ...toward our goal of protecting every Nevada seniors... preserving the strength and viability of our stat...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...ay 11 The Texas Cardiac Arrhythmia Institute (TCA...than 2,300 patients with heart rhythm disorders si...f them from outside Central Texas. , , "In just o...as drawn thousands of patients for the advanced tr...
...11 One year after an 8.0 magnitude earthquake kil...ated 5 million houses in southwest China, communit...ry. The focus has shifted from putting up prefabri...their emotional trauma. , , (Logo: http://www.n...
... Three military veterans with ALS and the ...LS (amyotrophic lateral sclerosis) have placed a w...y sponsored by The ALS Association. , ... (amyotrophic lateral sclerosis) have placed a wre...
...ay 11 The American College of Medical Genetics Fo...r new directors, following its 2009 annual meeting...ving as advocates for the Foundation and for advan...CMG , Professor in the Departments of Pathology &a...
... Today, Functionalab, a revolutionary new line of...aunch exclusively at the prestigious Henri Bendel ...igned to offer a beauty-nutrition balance, was dev... quality, potency and effectiveness. , , Functi...
... In federal court litigation, Johns v Blue Cross B...ntiff Christopher Johns contends that Blue Cross i... son, even though it was covered by his insurance ... and was administered by such prestigious hospital...
Other Medicine News:Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 3Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 4Health News:The Red Cross is Helping to Build More Than 100,000 Houses One Year After the Sichuan Earthquake 2Health News:Military Veterans Struck Down by Lou Gehrig's Disease Honored on Mother's Day by The ALS Association with Wreath Laying Ceremony at Arlington National Cemetery 2Health News:New Board Members Join American College of Medical Genetics Foundation (ACMGF): Distinguished Executive, Medical and Philanthropic Leaders Bring Additional Perspectives to the ACMGF Board 2Health News:New Board Members Join American College of Medical Genetics Foundation (ACMGF): Distinguished Executive, Medical and Philanthropic Leaders Bring Additional Perspectives to the ACMGF Board 3Health News:Functionalab Launches Exclusively at Henri Bendel Monday, May 11th, 2009 2Health News:Blue Cross Reverses Position on Autism After Federal Court Litigation Intensifies 2
(Date:11/19/2009)...wan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a le...redients (APIs), announced that its,Tainan facilit...ation from,SafeBridge(R) Consultants, Inc. The Cer...oficiency in the safe handling of potent active,ph...ecific laboratories and,production areas used for ...
(Date:11/19/2009)...., Nov. 19 The D e al...of its Most Admired Corporate Dealmakers for the s... as its Most Admired Dealmaker in pharma/biotech f...s and divestitures since January 2006. ,, Over ...portfolio with a focus on high-growth, innovation-...
(Date:11/19/2009)...national Internet Week of Action ,, SILVER SPR....S. Food and Drug Administration today completed a...ed the International Internet Week of Action (IIWA...cal products. ,, (Logo: http://www.newscom.com...effort, the FDA,s Office of Criminal Investigation...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Physician Hospitals of America Charges 3A Hospital Associations Bargain Away 24155 Billion in Medicare Funding in Attempt to Destroy Physician Hospit 51139 1Physician Hospitals of America Charges 3A Hospital Associations Bargain Away 24155 Billion in Medicare Funding in Attempt to Destroy Physician Hospit 51139 2Physician Hospitals of America Charges 3A Hospital Associations Bargain Away 24155 Billion in Medicare Funding in Attempt to Destroy Physician Hospit 51139 3Changes Reduced Infections From Medical Abortion 51137 1Changes Reduced Infections From Medical Abortion 51137 2Changes Reduced Infections From Medical Abortion 51137 3Stem Cells 26apos 3B 26quot 3BSuspended 26quot 3B State Preserved by Key Step Scientists Report 51134 1Stem Cells 26apos 3B 26quot 3BSuspended 26quot 3B State Preserved by Key Step Scientists Report 51134 2Stem Cells 26apos 3B 26quot 3BSuspended 26quot 3B State Preserved by Key Step Scientists Report 51134 3Stem Cells 26apos 3B 26quot 3BSuspended 26quot 3B State Preserved by Key Step Scientists Report 51134 4
...5 Immtech Pharmaceuticals,Inc. (Amex: IMM ) anno...Fin(TM) Rodman & Renshaw 9th Annual Healthcare Con...ern Time, Immtech is scheduled,to present in the H...el in,New York City. Immtech will hold a conferen...o present an update on the Company,s progress. The...
...5 Immtech Pharmaceuticals,Inc. (Amex: IMM ) toda... a,scientific consortium led by the University of ...d funds from The Bill & Melinda Gates Foundation,(...ting African sleeping,sickness (trypanosomiasis) a...lion the Gates Foundation has granted to the UNC-l...
Other Medicine Technology:Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
SterilGARDIII Advance; SG-603
ANALYTICAL BALANCE AW220
A&D HM-120
...reagents including linear polyacrylamide gel (LPA...ased infrared dyes- coupled with online denaturati...ul raw data, and higher-quality final analyses. A...x sequences, filling in the gaps with high-quality...
Medicine Products: